Primary amenorrhea and XY karyotype: Identifying patients in risk;Amenorréia primária e cariótipo XY: Identificando pacientes em risco

Revista Brasileira de Ginecologia e Obstetricia

Volumn 30, Issue 11, 2008, Pages 566-572

  Rosa, Rafael Fabiano Machado ^a,b   Dibi, Raquel Papandreus ^a,c   Toscani, Nadima Vieira ^a   Da Silva, Leonardo Leiria Moura ^a   Zen, Paulo Ricardo Gazzola ^a,b   Graziadio, Carla ^a,b   Paskulin, Giorgio Adriano ^a,b  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^b Faculdade Federal de Ciências Médicas de Porto Alegre   (Brazil)

^c Serviço de Ginecologia e Obstetrícia   (Brazil)

Author keywords

17 alpha hydroxylase; 46,XY gonadal dysgenesis; Amenorrhea; Androgen receptors; Dihydrotestosterone; Sexual differentiation; Testosterone; Y chromosome

Indexed keywords

ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; FEMALE; GENETICS; HUMAN; KARYOTYPING; PEDIGREE; PREVALENCE; RISK FACTOR; SEX CHROMOSOME ABERRATION;

ADOLESCENT; ADULT; AMENORRHEA; FEMALE; HUMANS; KARYOTYPING; PEDIGREE; PREVALENCE; RISK FACTORS; SEX CHROMOSOME ABERRATIONS; YOUNG ADULT;

EID: 58649116917     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0100-72032008001100007     Document Type: Article

References (28)

1. Ten SK, Chin YM, Noor PJ, Hassan K. Cytogenetic studies in women with primary amenorrhea. Singapore Med J. 1990;31(4):355-9.
2. Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertil Steril. 2006;86(5 Suppl):S148-55.
3. van Niekerk WA. Chromosomes and the gynecologist. Am J Obstet Gynecol. 1978;130(8):862-75.
4. Opitz O, Zoll B, Hansmann I, Hinney B. Cytogenetic investigation of 103 patients with primary or secondary amenorrhea. Hum Genet. 1983;65(1):46-7.
5. Wong MS, Lam ST. Cytogenetic analysis of patients with primary and secondary amenorrhoea in Hong Kong: retrospective study. Hong Kong Med J. 2005;11(4):267-72.
6. D'Agostini C, Gus R, Capp E, Corleta HVE. Estudo citogenético das gônadas em pacientes com amenorréia primária. Rev Bras Ginecol Obstet. 2005;27(3):125-9.
7. MacMahon RA, Cussen LJ, Walters WA. Importance of early diagnosis and gonadectomy in 46, XY females. J Pediatr Surg. 1980;15(5):642-5.
8. Hackel C, Oliveira LEC, Toralles MB, Nunes-Silva D, Tonini MMO, Ferraz LFC, et al. Deficiência de 5á-redutase tipo 2: experiências de Campinas (SP) e Salvador (BA). Arq Bras Endocrinol Metab. 2005;49(1):103-11.
9. Galani A, Kitsiou-Tzeli S, Sofokleous C, Kanavakis E, Kalpini-Mavrou A. Androgen insensitivity syndrome: clinical features and molecular defects. Hormones (Athens). 2008;7(3):217-29.
10. Behtash N, Karimi Zarchi M. Dysgerminoma in three patients with Swyer syndrome. World J Surg Oncol. 2007;5:71.
11. Michala L, Goswami D, Creighton SM, Conway GS. Swyer syndrome: presentation and outcomes. BJOG. 2008;115(6):737-41.
12. Hackel C, Oliveira LE, Ferraz LF, Tonini MM, Silva DN, Toralles MB, et al. New mutations, hotspots, and founder effects in Brazilian patients with steroid 5α-reductase deficiency type 2. J Mol Med. 2005;83(7):569-76.
13. Silva EA, Siqueira AC, Pacheco S, Ribeiro AK. Hiperplasia adrenal congênita - deficiência de 17á-hidroxilase. Arq Bras Endocrinol Metab. 2000;44(2):175-7.
14. Garel L. Abnormal sex differentiation: who, how and when to image. Pediatr Radiol. 2008;38 Suppl 3:S508-11.
15. Hughes IA. Disorders of sex development: a new definition and classification. Best Pract Res Clin Endocrinol Metab. 2008;22(1):119-34.
16. Anglani F, Baccichetti C, Artifoni L, Lenzini E, Tenconi R. Frequency of abnormal karyotypes in relation to the ascertainment method in females referred for suspected sex chromosome abnormality. Clin Genet. 1984;25(3):242-7.
17. Chryssikopoulos A, Grigoriou O. The etiology in 77 primary amenorrhea patients. Int J Fertil. 1987;32(3):245-9.
18. Corrêa RV, Wey JC, Billerbeck AEC, Melo KFS, Mendonça BB, Wey MV, et al. Insensibilidade completa aos andrógenos em pacientes brasileiras causada pela mutação P766A no gene do receptor androgênico. Arq Bras Endocrinol Metab. 2005;49(1):98-102.
19. Chen CP, Chern SR, Wang TY, Wang W, Wang KL, Jeng CJ. Androgen receptor gene mutations in 46,XY females with germ cell tumours. Hum Reprod. 1999;14(3):664-70.
20. Melo KF, Mendonça BB, Billerbeck AE, Costa EM, Inácio M, Silva FA, et al. Clinical, hormonal, behavioral, and genetic characteristics of androgen insensitivity syndrome in a Brazilian cohort: five novel mutations in the androgen receptor gene. J Clin Endocrinol Metab. 2003;88(7):3241-50.
21. Alvarez-Nava F, Gonzalez S, Soto M, Martinez C, Prieto M. Complete androgen insensitivity syndrome: clinical and anatomopathological findings in 23 patients. Genet Couns. 1997;8(1):7-12.
22. Cheikhelard A, Morel Y, Thibaud E, Lortat-Jacob S, Jaubert F, Polak M, et al. Long-term follow up and comparison between genotype and phenotype in 29 cases of complete androgen insensitivity syndrome. J Urol. 2008;180(4):1496-501.
23. Iliopoulos D, Volakakis N, Tsiga A, Rousso I, Voyiatzis N. Description and molecular analysis of SRY and AR genes in a patient with 46, XY pure gonadal dysgenesis (Swyer syndrome). Ann Genet. 2004;47(2):185-90.
24. Selvaraj K, Ganesh V, Selvaraj P. Successful pregnancy in a patient with a 46, XY karyotype. Fertil Steril. 2002;78(2):419-20.
25. D'Alberton A, Reschini E, Motta T, Catania A. Male pseudohermaphroditism due to 17-hydroxylase deficiency. J Endocrinol Invest. 1989;12(3):193-6.
26. De Marinis L, Mancini A, Saporosi A, Calabrò F, Massari M, Moneta E, et al. Male pseudohermaphroditism caused by 17-alpha-hydroxylase deficiency. Personal case reports and a review of the literature. Minerva Ginecol. 1989;41(7):337-42.
27. Bertelloni S, Scaramuzzo RT, Parrini D, Baldinotti, Tumini S, Ghirri P. Early diagnosis of 5α-reductase deficiency in newborns. Sex Dev. 2007;1(3):147-51.
28. Baldinotti F, Majore S, Fogli A, Marrocco G, Ghirri P, Vuerich M, et al. Molecular characterization of 6 unrelated Italian patients with 5α-reductase type 2 deficiency. J Androl. 2008;29(1):20-8.